Objectif The drug development strategy currently pursued by the pharmaceutical industry worldwide is inefficient and unsustainable for the health care system. To keep the latter affordable, drug development should become more efficient and drug treatment should become more “personalized” and “rationalized”. Molecular imaging can play a pivotal role in changing the landscape of drug design/development and improving the health care system. Positron Emission Tomography (PET) imaging, in particular, is the technology that has the potential to lead this fundamental innovation by providing at a much earlier stage reliable answers to key questions emerging during the care cycle: what and where is the disease? Is the disease accurately targeted by the therapy? Is the treatment effective? By answering the questions above, PET imaging has the capacity to render much more effectively the transition from pre-clinical to clinical phase, and to strongly facilitate the development of better drugs at an earlier stage and in a much more sustainable manner. The main obstacle to this change of paradigm in drug design and development is the lack of suitably trained translational scientists directly involved in PET imaging and imaging scientists with high-profile training in chemistry and PET-radiochemistry, which is particularly dramatic in Europe. This consortium is ideally suited to fill this gap, by providing top-quality training to the next generation of translational PET imaging scientists who will play a key role in shaping the future of drug design and development. The PET3D ETN will focus on 15 cutting-edge research projects in the 3 main therapeutic areas (oncology, cardiovascular, central nervous system) that will be conducted by 15 ESRs at 8 European beneficiary Institutions, 6 academic (all having a PET center on site) and 2 non-academic (one with a PET center on site and one big pharmaceutical company) representing the drug design and development terminus of the project. Champ scientifique sciences médicales et de la santémédecine fondamentalepharmacologie et pharmaciedécouverte de médicamentssciences médicales et de la santémédecine fondamentalechimie médicinalesciences médicales et de la santémédecine cliniqueradiologiemédecine nucléairesciences médicales et de la santémédecine cliniqueoncologiesciences médicales et de la santémédecine cliniquecardiologie Programme(s) H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions Main Programme H2020-EU.1.3.1. - Fostering new skills by means of excellent initial training of researchers Thème(s) MSCA-ITN-2015-ETN - Marie Skłodowska-Curie Innovative Training Networks (ITN-ETN) Appel à propositions H2020-MSCA-ITN-2015 Voir d’autres projets de cet appel Régime de financement MSCA-ITN-ETN - European Training Networks Coordinateur LOUGHBOROUGH UNIVERSITY Contribution nette de l'UE € 165 187,34 Adresse Ashby road LE11 3TU Loughborough Royaume-Uni Voir sur la carte Région East Midlands (England) Leicestershire, Rutland and Northamptonshire Leicestershire CC and Rutland Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Autres sources de financement € 0,00 Participants (9) Trier par ordre alphabétique Trier par contribution nette de l'UE Tout développer Tout réduire STICHTING VU Participation terminée Pays-Bas Contribution nette de l'UE € 0,00 Adresse De boelelaan 1105 1081 HV Amsterdam Voir sur la carte Région West-Nederland Noord-Holland Groot-Amsterdam Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Autres sources de financement € 0,00 VRIJE UNIVERSITEIT BRUSSEL Belgique Contribution nette de l'UE € 501 120,00 Adresse Pleinlaan 2 1050 Bruxelles / brussel Voir sur la carte Région Région de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest Région de Bruxelles-Capitale/ Brussels Hoofdstedelijk Gewest Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Autres sources de financement € 0,00 UNIVERSITETET I BERGEN Norvège Contribution nette de l'UE € 572 550,48 Adresse Museplassen 1 5020 Bergen Voir sur la carte Région Norge Vestlandet Vestland Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Autres sources de financement € 0,00 ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES- CIC biomaGUNE Espagne Contribution nette de l'UE € 495 745,92 Adresse Paseo miramon 182, parque tecnologico de san sebastian edificio empresarial c 20009 San sebastian Voir sur la carte Région Noreste País Vasco Gipuzkoa Type d’activité Research Organisations Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Autres sources de financement € 0,00 UNIVERSITAT MUNSTER Allemagne Contribution nette de l'UE € 498 432,96 Adresse Schlossplatz 2 48149 Munster Voir sur la carte Région Nordrhein-Westfalen Münster Münster, Kreisfreie Stadt Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Autres sources de financement € 0,00 IMANOVA LIMITED Royaume-Uni Contribution nette de l'UE € 273 287,88 Adresse Burlington danes building, imperial college london hammersmith hospital, du cane road W12 0NN London Voir sur la carte Région London Inner London — West Kensington & Chelsea and Hammersmith & Fulham Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Autres sources de financement € 0,00 ASTRAZENECA AB Suède Contribution nette de l'UE € 263 659,32 Adresse Vastra maelarhamnen 151 85 Sodertaelje Voir sur la carte Région Östra Sverige Stockholm Stockholms län Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Autres sources de financement € 0,00 STICHTING VUMC Pays-Bas Contribution nette de l'UE € 510 748,56 Adresse De boelelaan 1117 1081 HV Amsterdam Voir sur la carte Région West-Nederland Noord-Holland Groot-Amsterdam Type d’activité Research Organisations Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Autres sources de financement € 0,00 UNIVERSITY OF ABERDEEN Participation terminée Royaume-Uni Contribution nette de l'UE € 620 515,32 Adresse King's college regent walk AB24 3FX Aberdeen Voir sur la carte Région Scotland North Eastern Scotland Aberdeen City and Aberdeenshire Type d’activité Higher or Secondary Education Establishments Liens Contacter l’organisation Opens in new window Site web Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Autres sources de financement € 11 386,99
